Evercore ISI analyst Elizabeth Anderson raised the firm’s price target on Labcorp (LH) to $300 from $285 and keeps an Outperform rating on the shares following what the firm called a “solid” Q2 report. The firm is raising its 2025 EPS estimate to $16.41 from $16.09, citing continuing strong utilization trends, share gains and strong specialty growth in diagnostics, among other factors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH:
- Early notable gainers among liquid option names on July 24th
- Labcorp Holdings: Strong Performance, Strategic Growth, and Valuation Advantage Support Buy Rating
- Morning Movers: Dow Inc. falls following Q2 report and dividend cut
- Labcorp Holdings: Strategic Acquisitions and Growth Initiatives Drive Buy Rating
- Labcorp raises FY25 adjusted EPS view to $16.05-$16.50 from $15.70-$16.40